Literature DB >> 14710388

Clinical trials for pulmonary metastasectomy.

Amit N Patel1, Jason Lamb, Nilesh Patel, Ricardo S Santos, Christos Stavropoulos, Rodney J Landreneau.   

Abstract

There remains great controversy as to the indications and true benefits for pulmonary metastasectomy. The number of metastatic lesions, length of disease-free interval, and unilaterality has shown to be important prognostic factors on overall survival. In this review, we evaluate a number of clinical trials and critically assess the rational to perform pulmonary metastasectomy, which is a local treatment for a systemic disease process.

Mesh：

Substances：

Year:  2003        PMID： 14710388     DOI： 10.1053/j.semtcvs.2003.10.001

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN： 1043-0679


  6 in total

1.  Pulmonary metastases in children with osteosarcoma: characteristics and impact on patient survival.

Authors:  Darshana D Rasalkar; Winnie C W Chu; Vincent Lee; Bhawan K Paunipagar; Frankie W T Cheng; Chi Kong Li
Journal:  Pediatr Radiol       Date:  2010-09-03

2.  Benefits of video-assisted thoracic surgery for repeated pulmonary metastasectomy.

Authors:  Ryoichi Kondo; Kazutoshi Hamanaka; Satoshi Kawakami; Takashi Eguchi; Gaku Saito; Akira Hyougotani; Takayuki Shiina; Makoto Kurai; Kazuo Yoshida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-10-13

3.  Prognostic factors of pulmonary metastasectomy for colorectal carcinomas.

Authors:  Fengshi Chen; Nobuharu Hanaoka; Kiyoshi Sato; Takuji Fujinaga; Makoto Sonobe; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

4.  Pulmonary resection for metastases from hepatocellular carcinoma.

Authors:  Fengshi Chen; Kiyoshi Sato; Takuji Fujinaga; Makoto Sonobe; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

5.  Pulmonary resection for metastatic head and neck cancer.

Authors:  Fengshi Chen; Makoto Sonobe; Kiyoshi Sato; Takuji Fujinaga; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

6.  Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors.

Authors:  Xiaoliang Zhao; Xiaohua Wen; Wei Wei; Yulong Chen; Jianquan Zhu; Changli Wang
Journal:  Oncotarget       Date:  2017-07-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.